Ever wanted to trap Ezio Auditore da Firenze in an eternal acrylic cell (and on the blockchain)? Your time is now.
, the NFTs attached to the cubes will be stored on the Polygon blockchain , and you'll be able to play with them using a downloadable app.
Once you've purchased your non-fungible Ezio , you'll be able to rouse him from his slumber on your mobile device and customise him using IRL's"Soul Customizer," a theologically enterprising name for what is, in essence, a wardrobe. In there, you'll be able to"Customize your outfit, weapon, and pose" and"forge your digital soul into a unique Smart Collectible".
Deutschland Neuesten Nachrichten, Deutschland Schlagzeilen
Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.
Ubisoft has licensed a series of Assassin’s Creed NFTs | VGCUbisoft has licensed a series of Assassin's Creed NFTs which can be produced as 3D-printed physical collectibles.
Weiterlesen »
Ubisoft plans to increase the number of Assassin’s Creed developers by 40% | VGCUbisoft plans to increase the number of developers working on the Assassin’s Creed franchise by 40% over the coming years. It currently has at least six new series entries in development
Weiterlesen »
Greggs opens another branch the city centre - just a short walk from two othersGreggs opens another branch the city centre - just a short walk from two other stores
Weiterlesen »
Law proposed to 'ease distress' caused to rape victims in police investigationsNew law proposed to 'ease distress' caused to rape victims in police investigations
Weiterlesen »
CAR-NKT cell therapy: a new promising paradigm of cancer immunotherapy - Cancer Cell InternationalToday, cancer treatment is one of the fundamental problems facing clinicians and researchers worldwide. Efforts to find an excellent way to treat this illness continue, and new therapeutic strategies are developed quickly. Adoptive cell therapy (ACT) is a practical approach that has been emerged to improve clinical outcomes in cancer patients. In the ACT, one of the best ways to arm the immune cells against tumors is by employing chimeric antigen receptors (CARs) via genetic engineering. CAR equips cells to target specific antigens on tumor cells and selectively eradicate them. Researchers have achieved promising preclinical and clinical outcomes with different cells by using CARs. One of the potent immune cells that seems to be a good candidate for CAR-immune cell therapy is the Natural Killer-T (NKT) cell. NKT cells have multiple features that make them potent cells against tumors and would be a powerful replacement for T cells and natural killer (NK) cells. NKT cells are cytotoxic immune cells with various capabilities and no notable side effects on normal cells. The current study aimed to comprehensively provide the latest advances in CAR-NKT cell therapy for cancers.
Weiterlesen »